P. Auby

发表

Special challenges in paediatric recruitment

K. Allegaert, P. Auby, 2020 .

Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-controlled trial.

D. Sack, R. Mcquade, D. Oren, 2007, The Journal of clinical psychiatry.

Why do we need to publish paediatric data?

P. Auby, 2020 .

The European Union Pediatric legislation: impact on pharmaceutical research in pediatric populations

P. Auby, 2014 .

Preliminary and ongoing French multicenter prospective naturalistic study of adverse events of antipsychotic treatment in naive children and adolescents

F. Askénazy, P. Auby, S. Thümmler, 2014, Child and Adolescent Psychiatry and Mental Health.

Study design and methodology

P. Auby, 2020, Clinical Research in Paediatric Psychopharmacology.

A 6-Month Open-Label Extension Study of Vortioxetine in Pediatric Patients with Depressive or Anxiety Disorders

M. DelBello, R. Findling, M. Huss, 2017, Journal of child and adolescent psychopharmacology.

Emergence of psychiatric adverse events during antipsychotic treatment in AP-naïve children and adolescents

F. Askénazy, O. Bonnot, P. Auby, 2022, Child and Adolescent Psychiatry and Mental Health.

Antipsychotic prescribing patterns in Germany: a retrospective analysis using a large outpatient prescription database.

Werner Kissling, J. Hamann, A. Ruppert, 2003 .

A 3-year retrospective study of 866 children and adolescent outpatients followed in the Nice Pediatric Psychotrauma Center created after the 2016 mass terror attack

F. Askénazy, Arnaud Fernandez, R. Zeghari, 2022, Frontiers in Psychiatry.

Pharmaceutical research in paediatric populations and the new EU Paediatric Legislation: an industry perspective

Philippe Auby, P. Auby, Philippe Auby, 2008, Child and adolescent psychiatry and mental health.

Child and adolescent psychopharmacology at the beginning of the 21st century

P. Auby, A. Parachikova, 2020 .

Emergence of psychiatric adverse events during antipsychotic treatment in AP-naïve children and adolescents

F. Askénazy, O. Bonnot, P. Auby, 2022, Child and Adolescent Psychiatry and Mental Health.

[Safeguarding the prescription of antipsychotics in the paediatric population: A French multicentric study in a treatment naïve population].

D. Cohen, F. Askénazy, O. Bonnot, 2013, L'Encephale.

Ethical aspects of research in paediatric psychopharmacology

J. Ivković, P. Auby, 2020 .

Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology

P. Auby, 2011 .

Management of Acute Agitation in Patients With Bipolar Disorder: Efficacy and Safety of Intramuscular Aripiprazole

R. Mcquade, D. Oren, D. Zimbroff, 2007, Journal of clinical psychopharmacology.

Antipsychotic prescribing patterns in Germany: a retrospective analysis using a large outpatient prescription database

Werner Kissling, J. Hamann, A. Ruppert, 2003, International clinical psychopharmacology.

Pharmacokinetics and Safety of Vortioxetine in Pediatric Patients

M. DelBello, R. Findling, M. Huss, 2017, Journal of child and adolescent psychopharmacology.

Historical perspective

P. Auby, 2020, Clinical Research in Paediatric Psychopharmacology.

Pharmaceutical research in paediatric populations and the new EU Paediatric Legislation: an industry perspective

P. Auby, Philippe Auby, 2008, Child and adolescent psychiatry and mental health.

Child and adolescent psychopharmacology at the beginning of the 21st century

P. Auby, A. Parachikova, 2020, Clinical Research in Paediatric Psychopharmacology.

P.2.121 Aripiprazole vs. haloperidol for maintained treatment effect in acute mania

M. Bourin, R. Mcquade, R. Sanchez, 2003, European Neuropsychopharmacology.

Worldwide paediatric regulations

P. Auby, 2020 .